Ehave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IV
09 févr. 2022 08h30 HE
|
Ehave
MIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its...
Ehave Issues Shareholder Letter and Provides Corporate Update
31 janv. 2022 08h30 HE
|
Ehave
MIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to...
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
08 déc. 2021 08h00 HE
|
Ehave
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin...
2021 Psychedelic Investor Guide Released
20 oct. 2021 08h30 HE
|
Ehave
MIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly...
Ehave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, Florida
12 oct. 2021 08h30 HE
|
Ehave
MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
30 sept. 2021 08h30 HE
|
Ehave
MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Announces Inclusion in the 2021 Psychedelic Investor Guide
27 sept. 2021 08h30 HE
|
Ehave
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...
Ehave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory Board
21 sept. 2021 08h30 HE
|
Ehave
MIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahul...
Ehave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly
07 sept. 2021 09h49 HE
|
Ehave
MIAMI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...
Ehave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital Software
25 août 2021 09h43 HE
|
Ehave
MIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced...